Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tamoxifen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00000529
What this trial is testing

Tamoxifen Study

Who this might be right for
Cardiovascular DiseasesCoronary DiseaseHeart Diseases+2 more
NSABP Foundation Inc
Not applicableUnknownNCT04292886
What this trial is testing

Thin Endometrium Undergoing Frozen-thawed Embryo Transfer

Who this might be right for
Thin Endometrium
Nanjing University 120
Large-scale testing (Phase 3)UnknownNCT05016349
What this trial is testing

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Who this might be right for
Breast Cancer Female
Mahmoud Ramadan mohamed Elkazzaz 160
Early research (Phase 1)Study completedNCT04080297
What this trial is testing

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Who this might be right for
Vasomotor Symptoms (VMS)
Que Oncology 21
Early research (Phase 1)Study completedNCT00001504
What this trial is testing

A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients

Who this might be right for
Breast CancerBreast Neoplasm
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00632723
What this trial is testing

IRESSA™ (Gefitinib) in Breast Cancer Patients

Who this might be right for
Breast Cancer
AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT02197897
What this trial is testing

Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

Who this might be right for
Bladder Cancer
Baylor College of Medicine 15
Testing effectiveness (Phase 2)Looking for participantsNCT06184750
What this trial is testing

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+3 more
National Cancer Institute (NCI) 200
Large-scale testing (Phase 3)UnknownNCT04046159
What this trial is testing

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Who this might be right for
Breast Ductal Carcinoma in Situ
National Taiwan University Hospital 810
Not applicableEnrolling By InvitationNCT04488614
What this trial is testing

Prospective Breast Cancer Biobanking

Who this might be right for
Breast Cancer
Helse Stavanger HF 1,200
Testing effectiveness (Phase 2)Study completedNCT00729586
What this trial is testing

Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial CarcinomaRecurrent Uterine Corpus CarcinomaStage IIIA Uterine Corpus Cancer+5 more
National Cancer Institute (NCI) 73
Large-scale testing (Phase 3)Study completedNCT00004205
What this trial is testing

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 8,028
Large-scale testing (Phase 3)Study completedNCT00041080
What this trial is testing

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer+2 more
National Cancer Institute (NCI) 139
Testing effectiveness (Phase 2)Study completedNCT00214110
What this trial is testing

Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
University of Wisconsin, Madison 100
Early research (Phase 1)Study completedNCT02835079
What this trial is testing

Treatment Effect of Tamoxifen on Patients With DMD

Who this might be right for
Duchenne Muscular Dystrophy
Hadassah Medical Organization 19
Not applicableUnknownNCT02311647
What this trial is testing

Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients

Who this might be right for
Endometrial Receptivity Post Tamoxifen Exposure
Sheba Medical Center 120
Early research (Phase 1)UnknownNCT04961632
What this trial is testing

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 75
Not applicableStudy completedNCT00965939
What this trial is testing

An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients

Who this might be right for
ER-positive Breast Cancer
Vlaamse Vereniging voor Obstetrie en Gynaecologie 300
Early research (Phase 1)Study completedNCT02586675
What this trial is testing

TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer

Who this might be right for
Breast CancerBreast Cancer - FemaleBreast Cancer - Male
H. Lee Moffitt Cancer Center and Research Institute 7
Early research (Phase 1)Study completedNCT01273168
What this trial is testing

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

Who this might be right for
Hormone Receptor-Positive BreastGynecologicDesmoid+1 more
National Cancer Institute (NCI) 40
Next Page